Uploaded June 2026 | Updated September 2026, 3 weeks ago
Starting July 1, 2026, millions of Medicare recipients can access Wegovy, Zepbound, and Foundayo — some of the most effective weight loss drugs on the market — for just $50 a month through a new federal program called the Medicare GLP-1 Bridge. But how we got here is a story of political reversals, a 20-year-old law born out of a pharmaceutical scandal, and a government program that may not last as long as anyone hopes.
• What the Medicare GLP-1 Bridge program is and who qualifies
• The three-tier BMI eligibility structure you need to understand
• How Biden tried to cover these drugs — and Trump killed it — and then brought it back
• The 2003 law (and the fen-phen scandal) blocking permanent coverage
• Why the $50 co-pay doesn't count toward your Part D out-of-pocket cap
• What to do if you're already on a GLP-1 and want to switch to save money
• What Congress will need to do to make this permanent
This program is real, it's starting soon, and the details matter. Watch before your next doctor's appointment.
TIMESTAMPS
00:00 Intro
01:30 What Is the Bridge Program?
03:30 Biden Tried First — The Political Backstory
06:12 Trump Kills It, Then Brings It Back
09:15 The 2003 Law & the Fen-Phen Scandal
12:29 What Congress Needs to Do
14:23 Why This Matters — The Big Picture
16:34 What to Do If You Qualify
18:42 What If I Already Loss The Weight?
20:17 Bottomline
21:01 Outro
Sources: UCHealth Today, KFF, Axios, STAT News, AJMC, Journalists' Resource, Congress.gov CRS, Obesity Medicine Association, AARP
=======================================================
Affiliate Links (I earn commission for qualifying purchases)
Join Fridays (GLP-1/TRT) Use Code RMZ: joinfridays.com/?via=RMZ
Gruns: grns.sjv.io/AgoLV7
========================================================
Social Links
tiktok.com/@roundmoundofzepbound
instagram.com/roundmoundofzepbound
========================================================
DISCLAIMER: No information provided here is to be construed as medical advice. Always consult with a licensed medical provider for medical advice.
#glp1 #zepbound #mounjaro #weightloss #weightlossjourney #glp #tirzepatide #semaglutide #wegovy #ozempic #menshealth #beforeandafter #beforeandafterweightloss
Starting July 1, 2026, millions of Medicare recipients can access Wegovy, Zepbound, and Foundayo — some of the most effective weight loss drugs on the market — for just $50 a month through a new federal program called the Medicare GLP-1 Bridge. But how we got here is a story of political reversals, a 20-year-old law born out of a pharmaceutical scandal, and a government program that may not last as long as anyone hopes.
• What the Medicare GLP-1 Bridge program is and who qualifies
• The three-tier BMI eligibility structure you need to understand
• How Biden tried to cover these drugs — and Trump killed it — and then brought it back
• The 2003 law (and the fen-phen scandal) blocking permanent coverage
• Why the $50 co-pay doesn't count toward your Part D out-of-pocket cap
• What to do if you're already on a GLP-1 and want to switch to save money
• What Congress will need to do to make this permanent
This program is real, it's starting soon, and the details matter. Watch before your next doctor's appointment.
TIMESTAMPS
00:00 Intro
01:30 What Is the Bridge Program?
03:30 Biden Tried First — The Political Backstory
06:12 Trump Kills It, Then Brings It Back
09:15 The 2003 Law & the Fen-Phen Scandal
12:29 What Congress Needs to Do
14:23 Why This Matters — The Big Picture
16:34 What to Do If You Qualify
18:42 What If I Already Loss The Weight?
20:17 Bottomline
21:01 Outro
Sources: UCHealth Today, KFF, Axios, STAT News, AJMC, Journalists' Resource, Congress.gov CRS, Obesity Medicine Association, AARP
=======================================================
Affiliate Links (I earn commission for qualifying purchases)
Join Fridays (GLP-1/TRT) Use Code RMZ: joinfridays.com/?via=RMZ
Gruns: grns.sjv.io/AgoLV7
========================================================
Social Links
tiktok.com/@roundmoundofzepbound
instagram.com/roundmoundofzepbound
========================================================
DISCLAIMER: No information provided here is to be construed as medical advice. Always consult with a licensed medical provider for medical advice.
#glp1 #zepbound #mounjaro #weightloss #weightlossjourney #glp #tirzepatide #semaglutide #wegovy #ozempic #menshealth #beforeandafter #beforeandafterweightloss
